These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12106632)

  • 21. Vasomotor and vascular effects of hormone replacement therapy.
    Ganz P
    Am J Cardiol; 2002 Jul; 90(1A):11F-16F. PubMed ID: 12106634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology.
    Kypreos KE; Zafirovic S; Petropoulou PI; Bjelogrlic P; Resanovic I; Traish A; Isenovic ER
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):256-68. PubMed ID: 24414281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of estrogen receptors in the vascular system.
    Rubanyi GM; Kauser K; Johns A
    Vascul Pharmacol; 2002 Feb; 38(2):81-8. PubMed ID: 12379954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor-alpha gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration.
    Tan E; Gurjar MV; Sharma RV; Bhalla RC
    Cardiovasc Res; 1999 Aug; 43(3):788-97. PubMed ID: 10690351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Differential ER-Alpha Versus ER-Beta Mediated Activation of eNOS in Ovine Uterine Artery Endothelial Cells.
    Pastore MB; Talwar S; Conley MR; Magness RR
    Biol Reprod; 2016 Jun; 94(6):139. PubMed ID: 27170438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notoginsenoside Ft1 activates both glucocorticoid and estrogen receptors to induce endothelium-dependent, nitric oxide-mediated relaxations in rat mesenteric arteries.
    Shen K; Leung SW; Ji L; Huang Y; Hou M; Xu A; Wang Z; Vanhoutte PM
    Biochem Pharmacol; 2014 Mar; 88(1):66-74. PubMed ID: 24440742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formononetin upregulates nitric oxide synthase in arterial endothelium through estrogen receptors and MAPK pathways.
    Sun T; Cao L; Ping NN; Wu Y; Liu DZ; Cao YX
    J Pharm Pharmacol; 2016 Mar; 68(3):342-51. PubMed ID: 26786718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology.
    Arnal JF; Laurell H; Fontaine C; Billon A; Calippe B; Lenfant F; Gourdy P
    Climacteric; 2009; 12 Suppl 1():12-7. PubMed ID: 19811234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vascular protective effects of estrogen.
    Farhat MY; Lavigne MC; Ramwell PW
    FASEB J; 1996 Apr; 10(5):615-24. PubMed ID: 8621060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial nitric oxide synthase and estrogen.
    Kappagoda CT
    Cardiovasc Res; 2000 Jul; 47(1):9-10. PubMed ID: 10869525
    [No Abstract]   [Full Text] [Related]  

  • 31. Selected contribution: cerebrovascular nos and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alpha.
    Geary GG; McNeill AM; Ospina JA; Krause DN; Korach KS; Duckles SP
    J Appl Physiol (1985); 2001 Nov; 91(5):2391-9; discussion 2389-90. PubMed ID: 11641386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean?
    Mendelsohn ME
    Circ Res; 2000 Nov; 87(11):956-60. PubMed ID: 11090536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogens and the vascular endothelium.
    Cid MC; Schnaper HW; Kleinman HK
    Ann N Y Acad Sci; 2002 Jun; 966():143-57. PubMed ID: 12114268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration in endothelial estrogen receptor expression: a potential key of vasculoprotection by estrogens?
    Arnal JF; Bayard F
    Circ Res; 2002 Nov; 91(9):759-60. PubMed ID: 12411388
    [No Abstract]   [Full Text] [Related]  

  • 35. Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5'-monophosphate-dependent mechanism.
    Liu D; Homan LL; Dillon JS
    Endocrinology; 2004 Dec; 145(12):5532-9. PubMed ID: 15319357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERbeta has nongenomic action in caveolae.
    Chambliss KL; Yuhanna IS; Anderson RG; Mendelsohn ME; Shaul PW
    Mol Endocrinol; 2002 May; 16(5):938-46. PubMed ID: 11981029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP.
    Darkow DJ; Lu L; White RE
    Am J Physiol; 1997 Jun; 272(6 Pt 2):H2765-73. PubMed ID: 9227556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase.
    Hien TT; Kim ND; Pokharel YR; Oh SJ; Lee MY; Kang KW
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):171-83. PubMed ID: 20546771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of estrogen on the vascular system.
    Tostes RC; Nigro D; Fortes ZB; Carvalho MH
    Braz J Med Biol Res; 2003 Sep; 36(9):1143-58. PubMed ID: 12937779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective actions of progesterone in the cardiovascular system: potential role of membrane progesterone receptors (mPRs) in mediating rapid effects.
    Thomas P; Pang Y
    Steroids; 2013 Jun; 78(6):583-8. PubMed ID: 23357432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.